Helvet Health launched new men's health treatment in Urology

FERRING Pharmaceuticals, a leader in men’s health, Urology and Endocrinology – amongst other therapeutic categories – selected Helvet Health to support the global launch of a novel treatment therapy for men facing the challenges of hypogonadism. Helvet Health is proud to have earned this new opportunity and looks forward to FERRING to enable Urologists and Endocrinologists in better addressing this important men’s health challenge.

How we can help you?